Use of anthracyclinone derivatives in amyloidosis
US5731313A · kind A · utility
11Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 1996 |
| Grant date | Mar 24, 1998 |
| Priority date | — |
| Expiry date | Apr 4, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides the new use in the treatment of amyloidosis with the anthracyclinone of formula (A) wherein R1, R2, R3, R4, and R5, are appropriate substituents. Some compounds of formula (A) are novel. Processes for their preparation and pharmaceutical composition containing them are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.